Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep 13;13(9):e0203110.
doi: 10.1371/journal.pone.0203110. eCollection 2018.

Trend analysis of major cancer statistics according to sex and severity levels in Korea

Minsu Ock  1 , Woong Jae Choi  2 , Min-Woo Jo  3
Affiliations

Trend analysis of major cancer statistics according to sex and severity levels in Korea

Minsu Ock et al. PLoS One. .

Abstract

Existing epidemiologic reports or studies of cancer statistics in Korea lack sufficient data on cancer severity distributions and observed survival rates. This study analyzed trends in major cancer statistics according to sex and severity levels in Korea from 2006 to 2013. We included eight cancers (hepatocellular carcinoma, and thyroid, colorectal, gastric, lung, prostate, breast, and cervical cancer), using Korea Central Cancer Registry data. Severity level was classified by Surveillance, Epidemiology, and End Results (SEER) stage as follows: localized, regional, distant, or unknown. Numbers of incident cancer cases from 2006 to 2013 were described by sex and SEER stage. We estimated up to 8-year observed survival rates of major cancers by sex and SEER stage, and provided prevalence rates by sex and SEER stage in 2011, 2012, and 2013. Although increases in new cancer cases are slowing and the total number of incident cancer cases in 2013 decreased for the first time since 2006, the number of prevalent cancer cases was 663,530 in 2013, an increase of 13.3% compared to 2011. Among the five cancers affecting both sexes, sex-related differences in 5-year observed survival rates for lung cancer were greatest in the localized stage (men, 31.9%; women, 48.1%), regional stage (men, 20.0%; women, 31.3%), and unknown stage (men, 24.3%; women, 37.5%). The sum of the proportions of localized and regional stages for thyroid and breast cancer was over 90% in 2013, while the sum of the proportions of localized and regional stages for lung cancer was only 56.7% in 2013. Differences in observed survival rates between men and women were prominent in lung cancer for all SEER stages. The reported epidemiologic data from this study can be used to obtain a more valid measure of cancer burden using a summary measure of population health.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Method of estimating prevalent cases.
Fig 2
Fig 2. Number of incident cases for six cancers in men according to SEER stage from 2006 to 2013.
Fig 3
Fig 3. Number of incident cases for seven cancers in women according to SEER stage from 2006 to 2013.
Fig 4
Fig 4. 8-year observed survival rates for six cancers in men by SEER stage.
Fig 5
Fig 5. 8-year observed survival rates for seven cancers in women by SEER stage.
See this image and copyright information in PMC

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359–386. 10.1002/ijc.29210 - DOI - PubMed
    1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol 2015;1(4):505–527. 10.1001/jamaoncol.2015.0735 - DOI - PMC - PubMed
    1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol 2016. [Epub ahead of print]. - PMC - PubMed
    1. Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2013. Cancer Res Treat 2016;48(2):436–450. 10.4143/crt.2016.089 - DOI - PMC - PubMed
    1. Gong YH, Yoon SJ, Jo MW, Kim A, Kim YA, Yoon J, et al. The Burden of Cancer in Korea during 2012: Findings from a Prevalence-Based Approach. J Korean Med Sci 2016;31 Suppl 2:S168–S177. - PMC - PubMed

Publication types

LinkOut - more resources